erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Elliott WC Treatment of primary syphilis. 1976 J Am Vener Dis Assoc pmid:1010777
Thompson SE Treatment of syphilis in pregnancy. 1976 J Am Vener Dis Assoc pmid:1010783
Budell JW Treatment of congenital syphilis. 1976 J Am Vener Dis Assoc pmid:1010784
Willeit A et al. [Personal experience with erythromycin in the treatment of respiratory tract infections]. 1976 Minerva Pediatr. pmid:1012219
Parikov VA et al. [Effectiveness of antimastitis preparations]. 1976 Veterinariia pmid:1014354
Boelaert J Importance of side effects in treating impetigo. 1992 Pharmacoeconomics pmid:10147114
Ruczaj D and Rambaud J [Erythromycin polymorphism]. 1976 Acta Pol Pharm pmid:1015336
Khosla SN and Khosla P Therapeutic evaluation of various drugs in giardiasis (a comparative trial). 1978 Mod Med Asia pmid:101765
Marra CA et al. Chlamydia trachomatis in adolescents and adults. Clinical and economic implications. 1998 Pharmacoeconomics pmid:10178647
Hofstetter A and Blenk H [Therapy of prostato-vesiculitis]. 1978 MMW Munch Med Wochenschr pmid:101836
Karlsson M et al. Genetic basis of macrolide and lincosamide resistance in Brachyspira (Serpulina) hyodysenteriae. 1999 FEMS Microbiol. Lett. pmid:10188254
Kinirons MT et al. Effects of ketoconazole on the erythromycin breath test and the dapsone recovery ratio. 1999 Br J Clin Pharmacol pmid:10190659
Mthwalo M et al. Antibiotic resistance of nasopharyngeal isolates of Streptococcus pneumoniae from children in Lesotho. 1998 Bull. World Health Organ. pmid:10191560
Isohanni MH et al. Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine. 1999 Pharmacol. Toxicol. pmid:10193676
Stenson BJ et al. Influence of erythromycin on establishment of feeding in preterm infants: observations from a randomised controlled trial. 1998 Arch. Dis. Child. Fetal Neonatal Ed. pmid:10194995
Dorner S and Barta A Probing ribosome structure by europium-induced RNA cleavage. 1999 Biol. Chem. pmid:10195431
Montenez JP et al. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. 1999 Toxicol. Appl. Pharmacol. pmid:10198278
Sakaeva DD and Lazareva DN [The effect of erythromycin on immunity in immunodeficiency]. 1999 Jan-Feb Eksp Klin Farmakol pmid:10198768
Jarrett F et al. Antibiotic bowel preparation and burn wound colonization. 1976 Surg Forum pmid:1019996
Scarpignato C and Pelosini I Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility. 1999 Can. J. Gastroenterol. pmid:10202210
Hall JA and Washabau RJ Diagnosis and treatment of gastric motility disorders. 1999 Vet. Clin. North Am. Small Anim. Pract. pmid:10202795
Vasil'ev TV et al. [Immediate results of treatment of syphilis with erythromycin simultaneously with bismuth preparations]. 1976 Vestn Dermatol Venerol pmid:1020453
MiliavskiÄ­ AI and Kostenko AM [Early prevention of syphilis (experimental study)]. 1976 Vestn Dermatol Venerol pmid:1020461
Sefton AM Macrolides and changes in the oral flora. 1999 Int. J. Antimicrob. Agents pmid:10204636
Vermeulen B et al. The formulation and stability of erythromycin-benzoyl peroxide in a topical gel. 1999 Int J Pharm pmid:10205634
Vyhnálek J [Distribution of erythromycin following intramuscular administration in laboratory animals]. 1978 Vet Med (Praha) pmid:102070
Mishra A et al. The effects of erythromycin on the electrocardiogram. 1999 Chest pmid:10208196
Imshenetskaia VF [Erythromycin penetration into the cerebrospinal fluid of patients]. 1976 Antibiotiki pmid:1020930
Burstin PP and Marshall CL Infectious mononucleosis and bilateral peritonsillar abscesses resulting in airway obstruction. 1998 J Laryngol Otol pmid:10209619
Tarsi R and Vitali C [Erythromycin: serum and urine levels following rectal administration (author's transl)]. 1976 Jul-Aug Ann Sclavo pmid:1020971
Lakritz J et al. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. 1999 Am. J. Vet. Res. pmid:10211682
McConnell SA and Amsden GW Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin. 1999 Pharmacotherapy pmid:10212011
Betriu C et al. Incidence of erythromycin resistance in Streptococcus pyogenes: a 10-year study. 1999 Diagn. Microbiol. Infect. Dis. pmid:10212752
Dubois J and St-Pierre C In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species. 1999 Diagn. Microbiol. Infect. Dis. pmid:10212753
Biedenbach DJ et al. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results. 1999 Diagn. Microbiol. Infect. Dis. pmid:10212755
Kim RB et al. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein. 1999 Pharm. Res. pmid:10213372
Torii A [Effective treatment in combination with erythromycin and cisapride for chronic idiopathic intestinal pseudo-obstruction (CIIP)]. 1999 Nihon Shokakibyo Gakkai Zasshi pmid:10214084
Bercault N and Linassier P [The value of sepsis isolation to diminish the spread of multidrug-resistant bacteria in intensive care. Consequences on the incidence of nosocomial infections]. 1999 Rev Med Interne pmid:10220829
Perez-Trallero E et al. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. 1999 Mar-Apr Emerging Infect. Dis. pmid:10221875
Jackson LA et al. Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline. 1999 Mar-Apr Emerging Infect. Dis. pmid:10221884
Bassetti M et al. Streptococcus pyogenes erythromycin resistance in Italy. 1999 Mar-Apr Emerging Infect. Dis. pmid:10221991
Siedlik PH et al. Erythromycin coadministration increases plasma atorvastatin concentrations. 1999 J Clin Pharmacol pmid:10234598
Tran JQ et al. Assessment of the potential pharmacokinetic and pharmacodynamic interactions between erythromycin and argatroban. 1999 J Clin Pharmacol pmid:10234600
Morris LA and Kanouse DE Consumer reactions to differing amounts of written drug information. 1980 Jul-Aug Drug Intell Clin Pharm pmid:10247887
Bystedt H et al. Concentrations of azidocillin, erythromycin, doxycycline and clindamycin in human mandibular bone. 1978 Int J Oral Surg pmid:102599
Klein JO Middle ear disease in children. 1976 Hosp Pract pmid:1026633
Gregotti C et al. [Effects of phenobarbital on the hepatic microsome metabolism of erythromycin in rats]. 1976 Boll. Soc. Ital. Biol. Sper. pmid:1027460
Melon J and Reginster M [Passage into normal salivary, lacrimal and nasal secretions of ampicillin and erythromycin administered intramuscularly]. 1976 Acta Otorhinolaryngol Belg pmid:1028340
Rosenthal AL et al. Polyacrylic bone cement containing erythromycin and colistin. I. In vitro bacteriological activity and diffusion properties of erythromycin, colistin and erythromycin/colistin comibination. 1976 J. Int. Med. Res. pmid:1028631
Stille W [Legionnaire's disease]. 1978 MMW Munch Med Wochenschr pmid:102952